Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.70
Bid: 2.60
Ask: 2.80
Change: -0.10 (-3.85%)
Spread: 0.20 (7.692%)
Open: 2.60
High: 2.50
Low: 2.50
Prev. Close: 2.60
VAL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Ediston signs 10-year lease with Marks & Spencer

Wed, 01st Mar 2023 20:09

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

----------

Ediston Property Investment Co PLC - Edinburgh-based real estate investment company - Completes a 10-year lease agreement on a newly created 21,000 square feet unit with Marks & Spencer Group PLC at Plas Coch Retail Park, Wrexham. Adds that M&S will pay a market rent 27% ahead of the independent valuer's estimated rental value. Does not disclose further financial details. "Securing a tenant of M&S's calibre is transformational for our asset and underscores the strength of the location and its attractiveness to national tenants. It also illustrates the preference of many retailers to choose out-of-town retail warehouse parks ahead of the high street and shopping centres as their favoured trading destinations," Investment Manager Calum Bruce comments.

----------

RTW Venture Fund Ltd - New York-based investor in life sciences, biopharmaceutical, and medical technology companies - Co-leads a USD200 million series A round in Cargo Therapeutics LCC. Says that Cargo plans to use the proceeds for a phase 2 clinical development program and its pipeline of next-generation CAR T-cell programs and technologies. Co-leads a USD45 Million series B-1 round in China-based pharmaceutical company Oricell Therapeutics Co Ltd. Says that the company plans to use the proceeds to support its core product clinical development in the US.

----------

Upland Resources Ltd - Malaysia-focused upstream oil and gas company - Says its joint venture partner in Sarawak Upland Big Oil Sdn Bhd conducted geological fieldwork as part of the works for the Block SK334 onshore Sarawak joint technical study. Says that the preliminary findings were promising. "Preliminary findings from the geological field work study have been positive, Upland notes within Block SK334 a number of areas of specific interest with analogous geological configuration and reservoir/trap/seal combinations as Brunei's nearby Belait formation which is host to a number of proven oil and gas discoveries and oilfields," Chief Executive Bolhassan Di comments.

----------

Contango Holdings PLC - natural resource development company with operations in Africa - Completes the construction of a small-scale coke battery at the Lubu Coal Project in Zimbabwe. Says that it has produced around 4 tonnes of coke, from a sample of washed coking coal from Lubu. "The completion of the pilot coke plant will now enable us to generate larger coke production for testing, something required to enable us to conclude discussions under our memorandum of understanding and, as required, provide additional samples to other parties who have expressed interest in coke produced from Lubu," CEO Carl Esprey comments.

----------

Alkemy Capital Investments PLC - London-based company focused on acquisitions in the mining and technology metals sectors - Notes the completion of the acquisition of Britishvolt Tees Valley Lithium, a planned GBP3.8 billion Lithium-ion Gigafactory in Northern England by Australian Lithium-ion battery company Recharge. Explains that Recharge and its subsidiary Tees Valley Lithium Ltd signed an agreement to negotiate and finalise a definitive offtake agreement to supply tolled low-carbon lithium hydroxide into Recharge's qualified supply chain. Says that the Britishvolt project will be the UK's first Gigafactory and create a strategic economic and security asset which will play a critical role in the UK's industrial and net zero strategies.

----------

Standard Chartered PLC - London-based, Asia-focused lender - Fully redeems its USD1.00 billion fixed rate resetting perpetual subordinated contingent convertible securities. Says that the securities will be cancelled. Plans to make an application to The Stock Exchange of Hong Kong Ltd for the withdrawal of the listing of the securities, following the redemption.

----------

Canadian Overseas Petroleum Ltd - Wyoming, US-focused oil and gas company - Says its operating affiliate, COPL America, received a covenant waiver from its senior lender. Records production of 1,080 barrels of oil a day in January and 1,200 bbl per day in February, and estimates that production is currently at 1,400 bbl per day. Explains that it experienced several "severe winter storms" at its Wyoming operations from late December to late February. "This has been a difficult winter in Wyoming and western North America in general. The weather we have experienced has been well above historical averages. The interruption in our production operations has been difficult for all of us," CEO & President Arthur Millholland comments.

----------

ValiRx PLC - Hatfield Heath, England-based life sciences company focused on early-stage cancer therapeutics and women's health - Incoporates Inaphaea BioLabs Ltd as a new wholly owned subsidiary of the company and the cornerstone of ValiRx's translational contract research organisation. Says Inaphaea will be headquartered in the its laboratory in MediCity in Nottingham and will offer a wide range of pre-clinical and drug discovery testing services to academic, biotech and pharmaceutical researchers. "After a great deal of hard work by the entire ValiRx team, I am pleased to share this news about the formation of Inaphaea; the first step of our longer term ambition to create the unique tCRO service offering for early stage drug development. Over the next few weeks, we intend to transfer our own projects into the Inaphaea lab to continue their progress," CEO Suzy Dilly comments.

----------

By Abby Amoakuh, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
6 Sep 2018 09:05

ValiRx enters 'very exciting' phase for cancer therapies

(Sharecast News) - ValiRx told investors on Thursday that its clinical-stage therapeutics had continued to demonstrate "significant potential" for addressing unmet medical needs in oncology.

Read more
14 Jun 2018 11:00

WINNERS & LOSERS SUMMARY: Rolls Royce Flies High With Planned Job Cuts

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.----------FTSE 100 - up 2.6%. The jet engine maker said it will cut

Read more
11 May 2018 16:43

Nicholas Slater Increases ValiRx Stake To 4.5% From 2.7% (ALLISS)

LONDON (Alliance News) - ValiRx PLC said Friday Nicholas Slater had almost doubled his stake in life science company, which focuses on cancer treatments, to 4.5% after a transaction on raised his

Read more
4 May 2018 17:08

ValiRx Raises GBP950,000 Through Placing To Progress Pipeline (ALLISS)

LONDON (Alliance News) - ValiRx PLC said Friday it has raised GBP950,000 through the issue of 47.5 million shares at 2.00 pence per share.The clinical stage biotechnology company's down

Read more
25 Apr 2018 13:41

"Major" Milestone As ValiRx's VAL201 Is Granted Patent In EU

LONDON (Alliance News) - Biotechnology company ValiRx PLC said Wednesday its VAL201 compound has been granted a patent in the EU.This, it said, follows a US patent which was granted for a a

Read more
19 Apr 2018 12:41

ValiRx Posts Positive Results From VAL101 Compound Pre-Clinical Trials

LONDON (Alliance News) - ValiRx PLC on Thursday said pre-clinical studies showed that its VAL101 compund has a potential to prevent cancer growth at cellular biochemical and genomic molecule is is

Read more
29 Mar 2018 00:12

UPDATE 1-Argentina Merval index to shrink to 28 companies in Q2

BUENOS AIRES, March 28 (Reuters) - Argentina's benchmark Merval stock index will shrink to 28 component companies in the second quarter, down from 31

Read more
28 Mar 2018 23:11

Argentina Merval index to shrink to 28 companies in Q2

BUENOS AIRES, March 28 (Reuters) - Argentina's benchmark Merval stock index will shrink to 28 component companies in the second quarter, down from 31

Read more
20 Mar 2018 13:55

ValirX Gets US Patent For Proposed VAL201 Cancer Treatment

LONDON (Alliance News) - Biotechnology firm ValirX PLC said Tuesday its VAL201 therapeutic compound has been granted a patent in the US.VAL201, which is currently in is

Read more
19 Mar 2018 12:46

YA II CD Lowers ValiRx Interest To Below 3% Threshold (ALLISS)

LONDON (Alliance News) - Life sciences firm ValiRx PLC said on Monday YA II CD Ltd has cut its stake in the company to below 3%.Prior to last Thursday's YA II CD a

Read more
11 Jan 2017 11:18

ValiRx upbeat on positive VAL201 study results

(ShareCast News) - Clinical stage biotechnology company ValiRx announced positive results in its VAL201 personalised Phase l/II prostate cancer study on Wednesday, adding that with accumulation of safety and tolerability data there is also evidence of disease stabilisation on CT imaging and reductio

Read more
11 Jan 2017 09:01

ValiRx To Expand VAL201 Studies After Positive Results

Read more
3 Nov 2016 11:40

ValiRx reports good progress at Georgia drug trial

(ShareCast News) - Life science company focused on clinical stage cancer therapeutic development, ValiRx, updated the market on the clinical development of its novel cancer treatment drug, VAL401. The AIM-traded firm said ValiSeek, the joint venture between ValiRx and Tangent Reprofiling, was formed

Read more
27 Sep 2016 10:17

ValiRx Interim Loss Widens As It Progresses Drug Pipeline

Read more
28 Jul 2016 08:41

ValiRx Gets Patent Coverage For VAL401 In New Zealand

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.